Plexus Capital

Plexus Capital is a Raleigh, North Carolina-based private equity firm that has spent nearly two decades backing founder and family-owned businesses in the lower middle market. With over $3.5 billion raised across nine funds and more than 200 platform investments since inception, Plexus has established itself as one of the most active participants in the space. In late 2025, the firm closed over $1.3 billion across two vehicles—Fund VII ($977 million) and Equity Fund II ($345 million)—signaling significant capital available for new transactions.

Unlike traditional venture capital firms, Plexus operates across two distinct strategies: a structured capital platform that combines debt with equity co-investments, and a buyout fund focused on control equity positions in founder-owned businesses. This flexibility allows Plexus to meet founders and management teams at various stages of their journey—whether they are selling a lifetime of work, funding an acquisition spree, or recapitalizing to take some chips off the table.

The firm's 2025 capital raise was substantially oversubscribed, reflecting limited partner confidence in Plexus's lower middle market approach. The firm targets companies with $2 million to $15 million of EBITDA and up to $150 million in revenue, typically investing $5 million to $40 million per transaction, with the ability to put $50 million or more to work in a single platform through delay-draw facilities and co-investment rights.

Plexus has also become a go-to capital partner for independent sponsors, search funds, and management teams who need a reliable funding source for add-on acquisitions. The firm has deployed $2.7 billion into over 200 platforms since inception, with a portfolio spanning healthcare, business services, consumer, industrials, technology, and niche manufacturing.

Understanding Plexus Capital's specific criteria, sector preferences, and deal structure approach is essential for any founder or business owner considering a partnership. This guide covers what the firm looks for, how the process works, and how to put your best foot forward when seeking capital from this active lower middle market investor.

Plexus Capital's investment thesis centers on partnering with businesses where capital facilitates meaningful change—typically a change of control, a generational transfer of ownership, or a growth initiative that exceeds what internal resources can support. The firm takes a partnership-oriented approach, working alongside management teams rather than imposing a top-down operational agenda.

The lower middle market is at the center of Plexus's strategy. In this segment, Plexus argues there is less competition for high-quality deals compared to larger markets, more opportunity to provide genuine operational support, and attractive risk-adjusted returns due to business model stability. Companies with $2 million to $15 million of EBITDA often have proven cash flows, established customer bases, and meaningful competitive positions—but they may lack the institutional expertise or capital to execute on the next stage of growth.

Plexus structures its capital in two primary ways. The structured capital strategy (Fund VII) combines senior debt with equity co-investment, allowing Plexus to back independent sponsors and management teams who want to acquire businesses but prefer a partnership structure over pure equity. The equity strategy (Equity Fund II) takes controlling stakes in founder-owned businesses, typically as part of a buyout or generational transition.

Sectors of conviction include business services, healthcare services, niche manufacturing, value-added distribution, consumer services, and software/IT services. Plexus does not shy away from industries that may seem unglamorous—they actively invest in sectors like industrial distribution, specialty chemicals, field services, and administrative support where durable cash flows and fragmented ownership create attractive buyout opportunities.

The firm looks for businesses with strong market dynamics—either in growing end markets or with positions that can be defended through customer relationships, recurring revenue metrics, or operational complexity that creates barriers to entry. Sustainable positive cash flow is a key filter. Plexus prefers companies where the underlying business does not depend on a single customer, a volatile end market, or aggressive working capital extraction.

Geographically, Plexus invests across North America for platform companies, with a concentration in the Southeast and Midwest where the firm has built deep relationships and sourcing networks. Add-on acquisitions for portfolio companies can be global.

Plexus Capital closed its most recent fundraising in late 2025 with over $1.3 billion in total capital commitments across two vehicles. Plexus Fund VII LP raised $977 million for the firm's structured capital strategy, which includes a mix of debt instruments and equity co-investments. Plexus Equity Fund II raised $345 million and reached its hard cap within three months of launching—a signal of strong limited partner demand and confidence in the team's track record.

This capital raise follows a consistent deployment pace. The prior fund, Plexus Fund VI, closed at $554 million in July 2023. The firm has now raised over $3.5 billion across nine funds since its founding in 2005, deploying into more than 200 platform companies and countless add-on acquisitions. This continuity of capital allows Plexus to be a reliable partner across multiple transactions with the same management team or sponsor.

For business owners and independent sponsors, the availability of committed capital is a practical consideration when evaluating a partnership. Plexus's ability to close reliably and move quickly—particularly in process-oriented transactions where sellers have multiple bidders—can be a meaningful differentiator against private equity firms that must navigate LP approval for every new platform.

The firm has demonstrated willingness to back newer independent sponsors and search funds, which are often at a disadvantage when competing against established private equity groups with proven track records. Plexus's structured capital approach allows these sponsors to access debt capital and co-investment alongside Plexus, effectively leveling the playing field when pursuing lower middle market acquisitions.

Plexus Capital has maintained an active deal pace through 2024 and 2025, deploying capital across both its structured capital and equity platforms. Several recent transactions illustrate the firm's approach and sector focus.

In early 2025, Plexus announced a growth partnership with ChemREADY, a Twinsburg, Ohio-based provider of commercial water treatment chemicals, equipment, and services. ChemREADY serves as the cornerstone of Plexus Capital's commercial water treatment platform, with the firm actively pursuing add-on acquisitions to build scale in the fragmented water treatment distribution space.

Also in 2025, Plexus co-founded ACE Solutions alongside AEG Petroleum and Grade A Petroleum. ACE Solutions is a national distributor of oil lubricants, diesel exhaust fluid, fuel, and related products, operating locations across Texas, Oklahoma, New Mexico, and New York. The transaction illustrates Plexus's willingness to seed new platforms with operator partners rather than simply acquiring existing businesses.

Plexus has also backed Watchtower Capital's acquisitions of Fence Builders in North Carolina and Green Hill Fence Company in South Carolina, demonstrating the firm's role as a capital partner for independent sponsors executing buy-and-build strategies. These transactions reflect the structured capital approach—Plexus providing debt and equity alongside a sponsor who sources and operates the platform.

The firm's historical portfolio shows investments spanning healthcare services (Coronis Health, Infinite Homecare, Health Perspectives Group), business services (Hayes Software Systems, Datacor Holdings, SuccessEd Holdings), consumer and retail (Grease Monkey International, Parker School Uniforms, Rice's Honey), niche manufacturing (Alloy Cladding, Mission Critical Electronics, NextPhase Medical Devices), and technology (LightRiver Technologies, CyberSheath, Ipro Tech). Exits have included strategic sales, secondary buyouts, and generational transfers across a wide range of sub-sectors.

Plexus Capital's portfolio reflects its sector breadth and deal flexibility. The firm's current active portfolio includes companies across healthcare, industrials, business services, consumer, and technology.

ACE Solutions, co-founded in 2025 with AEG and Grade A Petroleum, is a national distributor of lubricants, diesel exhaust fluid, and fuel products operating across Texas, Oklahoma, New Mexico, and New York. The platform is actively growing through acquisition and operational expansion.

ChemREADY, announced in early 2025, serves as the cornerstone of Plexus's commercial water treatment platform. Headquartered in Twinsburg, Ohio, the company provides chemicals, equipment, and services to commercial and industrial customers and is pursuing an active add-on acquisition strategy.

Legacy Lawns, backed by Plexus Equity Fund II, represents the firm's broader lawn and landscape services platform. Plexus has written publicly about the challenge and opportunity of scaling a fragmented service business while preserving the brand and culture that drove its success.

National Boiler Service and Southern Elevator are other active Equity Fund II holdings, representing Plexus's focus on specialized industrial services businesses with recurring revenue metrics characteristics and defensible market positions.

Riggs Tree Service rounds out the highlighted current portfolio, reflecting Plexus's appetite for essential services businesses in fragmented end markets. The firm has taken a long-term approach to building platform businesses across field services, arguing that the lower middle market offers underappreciated consolidation opportunities.

The firm's broader portfolio also includes Coronis Health (healthcare), Inspired Beauty Brands (consumer), Scivation (nutraceuticals), BroadcastMed (media and healthcare technology), and dozens of other companies across industrials, business services, and technology sub-sectors.

Plexus Capital evaluates investments based on a consistent set of criteria across both its structured capital and equity strategies. Understanding these filters is essential for founders or sponsors seeking to engage the firm.

Financial profile is the starting point. Plexus targets companies with $2 million to $15 million of EBITDA and up to $150 million in revenue. The firm looks for positive sustainable cash flow—businesses that are not dependent on aggressive working capital management or cyclical capital expenditures to generate returns. Strong market dynamics and proven business strategies are table stakes.

Ownership structure matters. Plexus has a documented preference for founder and family-owned businesses, where the incoming capital can facilitate a genuine generational transition or recapitalization. The firm also actively partners with independent sponsors and search funds, serving as a reliable capital source for their acquisition programs. Management teams with meaningful equity ownership and a genuine commitment to the next phase of growth are preferred.

Competitive positioning is evaluated carefully. Plexus looks for businesses with defensible market positions—whether through customer relationships, geographic density, proprietary products or services, regulatory barriers, or operational complexity that creates friction for new entrants. The firm is particularly attracted to businesses with recurring revenue metrics characteristics and high customer retention.

Growth path clarity is important. Plexus prefers businesses that have a clear and executable plan for value creation, typically through a combination of organic growth initiatives and add-on acquisitions. For the structured capital strategy, this often means backing sponsors who have identified a specific roll-up or buy-and-build thesis. For the equity strategy, it means partnering with management teams who have a credible view of how to double or triple the business over a five-to-seven-year hold period.

People and culture are increasingly central to Plexus's evaluation. The firm has built a culture around what it calls CARE values—Be an Athlete, Get in the Arena, Own and Hone Your Gifts, DWYSYWD (Do What You Said You Would Do), and Team First. While this may sound like corporate boilerplate, Plexus has demonstrated commitment to these values in how they work with portfolio company management teams. The firm looks for counterparties who share this ethos.

Plexus Capital sources the majority of its deals through relationships rather than cold inbound flow. For founders and independent sponsors, warm introductions from advisors, investment bankers, attorneys, or existing Plexus portfolio executives are the most effective way to secure an initial conversation.

The firm has built a reputation for being accessible to independent sponsors and search funds, a segment of the market that many larger private equity firms overlook or undervalue. Plexus's structured capital team, led by Partner Jay Jester, focuses specifically on supporting independent sponsors and management teams with flexible capital solutions. For equity investments, AJ Hamel and Ryne Collins serve as key contacts at the VP level, while Jay Jester leads buyout transactions as Head of Buyouts.

For business owners considering a sale or recapitalization, building a relationship with Plexus before running a formal process can pay dividends. The firm can provide perspective on valuation expectations, help frame the growth thesis, and—if there is a genuine fit—become a committed partner rather than a transactional bidder. Business owners who bring Plexus in early often get better outcomes than those who run a competitive auction.

Cold outreach is accepted but must be highly targeted. If you do not have a warm introduction, ensure your materials explain clearly why your business fits Plexus's investment criteria: EBITDA range, sector, ownership structure, and growth thesis. Generic pitches that do not reference Plexus's lower middle market focus or specific sector expertise will not stand out.

Once a relationship is established, expect Plexus to move with reasonable speed. The firm has a demonstrated ability to make decisions and close transactions, which is a meaningful advantage in lower middle market processes where慢了 competitors often have longer approval chains. Due diligence for a typical transaction takes four to eight weeks from initial meeting to close, depending on documentation readiness and deal complexity.

Plexus Capital invests in established businesses with proven cash flows, so financial preparedness is not optional—it is a prerequisite. The firm will conduct thorough due diligence on your financials, and having clean, well-organized books will significantly accelerate the process and increase your probability of closing.

Before approaching Plexus, ensure your EBITDA documentation is clean and reconciled. The firm targets companies with $2 million to $15 million of EBITDA, so your presentation of adjusted EBITDA must be credible and defensible. Expect Plexus to challenge add-backs and normalization adjustments—having supporting documentation for every adjustment is essential.

Clean cap table documentation is non-negotiable. Plexus will want to understand exactly who owns what, any outstanding options or warrants, and any related-party transactions that could create risk or complexity. Businesses with messy or unclear ownership structures are significantly less attractive to institutional capital providers.

Management team backgrounds and experience are part of the evaluation. Plexus wants to back committed management teams with domain expertise and a track record of execution. Ensure your leadership team's bios and relevant accomplishments are documented and ready to present.

A clear and credible growth strategy is important. Whether you are seeking capital for a buyout, an acquisition program, or organic growth initiatives, Plexus will want to understand the specific steps you plan to take and how the capital will drive returns. Be prepared to present a detailed plan with supporting market analysis.

Working with a fractional CFO or financial advisor before approaching Plexus can meaningfully improve your positioning. Professional guidance helps you build accurate projections, prepare investor-ready financials, and present your business in the best possible light. For business owners who have never raised institutional capital, this support is often the difference between a successful process and a frustrating one.

Whether you are preparing to pitch Plexus Capital or another lower middle market investor, having professional financials and a clear growth thesis sets you apart from the competition. Our team has helped numerous business owners and independent sponsors prepare for institutional capital raises and would be happy to discuss how we can support your process.

Exploring other private equity or growth equity firms? Our comprehensive collection of investor reviews covers firms across all stages, sectors, and check size ranges.

Each review provides detailed information about investment criteria, portfolio companies, and strategies for approaching the firm. Whether you are a founder selling your business, an independent sponsor building a platform, or a management team seeking growth capital, you will find relevant insights in our investor guides.

Finding the right capital partner for your business is crucial to your outcome. Take the time to research potential partners, understand their investment thesis, and engage early if there is a genuine fit.